

Founded in 2013, Pro-med is an innovative in vitro diagnostic (IVD) company specializing in high-end diagnostic solutions, integrating R&D, manufacturing, and sales.
Pro-med focuses on two core areas: Viscoelastic Testing (VET) and Immunoassay POCT, with the microfluidic thromboelastography analyzer ST-1000 and capillary blood Vitamin D testing as its core products. We are committed to providing faster, more accurate, and more convenient diagnostic solutions for clinical applications.
Pro-med is recognized as a National High-Tech Enterprise and National-level Specialized and Innovative “Little Giant” Enterprise, as well as a Beijing Enterprise Technology Center, Intellectual Property Advantage Enterprise, and Postdoctoral Research Station. Our core products have been included in the Beijing First (Set) of Major Technical Equipment Program for consecutive years, and we have established clinical and R&D collaborations with leading tertiary hospitals in China.
Guided by our mission of “Making Diagnostics Accessible and Protecting Human Health,” Pro-med continues to advance innovation in thromboelastography and immunoassay POCT, leveraging innovative technologies to accelerate the clinical adoption and global expansion of high-end IVD solutions. We are committed to becoming an internationally competitive high-end IVD brand.
To develop and manufacture high-performance IVD instruments and reagents, providing accurate and timely diagnostic evidence for healthcare professionals to improve patient outcomes.
To become a globally trusted IVD partner, bringing reliable and affordable diagnostic solutions to healthcare institutions worldwide.
Our people are our greatest asset. We respect our diverse team members and empower every colleague to deliver their best, as we work together to fulfill our mission.
